drug

Strategy Development

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by University of Toronto
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

1
Examining Strategy Monitoring and Remediation Training
NCT04756388—Completed

KOLs & investigators

1
Michael W Best, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of Toronto
company
trial
Examining Strategy Monitoring and Remediation Training
NA
trial
indication
Schizophrenia
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
Executive Dysfunction
indication
KOL
Michael W Best, PhD
KOL score —
person